Zoller, H.; Jenal, A.; Staettermayer, A.F.; Schroecksnadel, S.; Ferenci, P.; Fuchs, D.
Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism. Pharmaceuticals 2015, 8, 337-350.
https://doi.org/10.3390/ph8020337
AMA Style
Zoller H, Jenal A, Staettermayer AF, Schroecksnadel S, Ferenci P, Fuchs D.
Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism. Pharmaceuticals. 2015; 8(2):337-350.
https://doi.org/10.3390/ph8020337
Chicago/Turabian Style
Zoller, Heinz, Annina Jenal, Albert F. Staettermayer, Sebastian Schroecksnadel, Peter Ferenci, and Dietmar Fuchs.
2015. "Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism" Pharmaceuticals 8, no. 2: 337-350.
https://doi.org/10.3390/ph8020337
APA Style
Zoller, H., Jenal, A., Staettermayer, A. F., Schroecksnadel, S., Ferenci, P., & Fuchs, D.
(2015). Tryptophan Breakdown in Patients with HCV Infection is Influenced by IL28B Polymorphism. Pharmaceuticals, 8(2), 337-350.
https://doi.org/10.3390/ph8020337